Home/Pipeline/Anti-CCR8 antibody

Anti-CCR8 antibody

Cancer (likely solid tumors)

PreclinicalActive

Key Facts

Indication
Cancer (likely solid tumors)
Phase
Preclinical
Status
Active
Company

About LiberoThera

Japanese biotech developing antibody therapeutics using proprietary cell-free membrane protein and non-canonical amino acid technologies.

View full company profile

Therapeutic Areas